"Triglycerides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D014280
|
| MeSH Number(s) |
D10.351.801
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Triglycerides".
Below are MeSH descriptors whose meaning is more specific than "Triglycerides".
This graph shows the total number of publications written about "Triglycerides" by people in this website by year, and whether "Triglycerides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 2 | 3 |
| 1995 | 0 | 3 | 3 |
| 1996 | 2 | 4 | 6 |
| 1997 | 1 | 2 | 3 |
| 1998 | 0 | 2 | 2 |
| 1999 | 2 | 1 | 3 |
| 2000 | 1 | 5 | 6 |
| 2001 | 4 | 11 | 15 |
| 2002 | 3 | 6 | 9 |
| 2003 | 4 | 11 | 15 |
| 2004 | 4 | 12 | 16 |
| 2005 | 3 | 8 | 11 |
| 2006 | 6 | 14 | 20 |
| 2007 | 2 | 6 | 8 |
| 2008 | 11 | 11 | 22 |
| 2009 | 6 | 11 | 17 |
| 2010 | 4 | 16 | 20 |
| 2011 | 5 | 16 | 21 |
| 2012 | 5 | 21 | 26 |
| 2013 | 13 | 21 | 34 |
| 2014 | 10 | 20 | 30 |
| 2015 | 5 | 10 | 15 |
| 2016 | 6 | 7 | 13 |
| 2017 | 4 | 12 | 16 |
| 2018 | 4 | 7 | 11 |
| 2019 | 7 | 11 | 18 |
| 2020 | 1 | 10 | 11 |
| 2021 | 6 | 6 | 12 |
| 2022 | 0 | 12 | 12 |
| 2023 | 0 | 5 | 5 |
| 2024 | 4 | 6 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Triglycerides" by people in Profiles.
-
Comparative and combination study of simvastatin alone and in combination with Beta vulgaris in hyperlipidemia patients. Pak J Pharm Sci. 2024 Sep; 37(5):1033-1041.
-
Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non-HDL-C Levels. JAMA Cardiol. 2024 Aug 01; 9(8):741-747.
-
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial. JAMA Cardiol. 2024 Jul 01; 9(7):620-630.
-
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia. N Engl J Med. 2024 Sep 12; 391(10):913-925.
-
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia. N Engl J Med. 2024 Sep 12; 391(10):899-912.
-
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome. N Engl J Med. 2024 May 16; 390(19):1781-1792.
-
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. Eur Heart J. 2024 Apr 01; 45(13):1173-1176.
-
Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl. J Am Coll Cardiol. 2024 Apr 23; 83(16):1529-1539.
-
The association between dyslipidaemia in the first trimester and adverse pregnancy outcomes in pregnant women with subclinical hypothyroidism: a cohort study. Lipids Health Dis. 2024 Jan 11; 23(1):13.
-
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. Nat Commun. 2024 01 02; 15(1):79.